Bottom Line: Experts question government plans to rank general practices by referral times Poor professional performance is an unlikely cause of delays in referral for suspected cancer, argue researchers in[…]

The most comprehensive international comparison of cancer survival to date, covering countries that are home to two-thirds of the world’s population, shows extremely wide differences in survival between countries. The[…]

Bottom Line: A wild berry native to North America may strengthen the effectiveness of a chemotherapy drug commonly used to treat pancreatic cancer, reveals experimental research published online in the Journal[…]

Bottom Lines: Experts are calling for the ongoing trial into extended breast cancer screening to be halted. In a letter to The BMJ this week, Susan Bewley, Professor of Obstetrics at King’s College London and colleagues describe[…]